Global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests
Market-leading intelligence is the catalyst behind Novacyt’s ability to anticipate – and respond – to emerging new SARS-CoV-2 variants. Global tracking of virus mutations enables its R & D division to quickly develop tests that not only identify variants of concern (VOCs) – originally identified in countries such as the UK, Brazil, South Africa etc – in less than two hours but also identify and add mutations that are likely to become biologically relevant. Novacyt’s bioinformatics surveillance group has worked with [...]